New England Biolabs Launches Enzymatic 5hmC Detection Kit
New England Biolabs launched the NEBNext Enzymatic 5hmC-seq Kit, a novel enzyme-based method for the specific detection of 5hmC sites.
Read MorePosted by Andy Lundin | Feb 13, 2024 | Diagnostic Technologies |
New England Biolabs launched the NEBNext Enzymatic 5hmC-seq Kit, a novel enzyme-based method for the specific detection of 5hmC sites.
Read MorePosted by Chris Wolski | Feb 1, 2024 | Emerging & Zoonotic Diseases |
Picodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read MorePosted by Andy Lundin | Jan 31, 2024 | Diagnostic Technologies |
The agreement represents a milestone of the COVID-19 Technology Access Pool initiative as it enables the manufacture of diagnostic solutions.
Read MorePosted by Andy Lundin | Jan 22, 2024 | Covid 19 |
Analysis of blood samples from patients with Long COVID has revealed serum protein changes as the likely culprit.
Read MorePosted by Chris Wolski | Jan 19, 2024 | Middleware & Software |
Low-code LIMS offer an adaptable, nimble platform, facilitating quick customization to cater to the specific, individualized needs of a lab.
Read More